Asbestos and Lung Cancer

Disease-a-Month

Volumn 57, Issue 1, 2011, Pages 55-68

  Suvatne, Jimmy ^a   Browning, Robert F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; BETA CAROTENE; RETINOL; TAMOXIFEN;

ARTICLE; ASBESTOSIS; BREAST CANCER; CANCER DIAGNOSIS; CANCER SCREENING; CANCER SURGERY; ENVIRONMENTAL EXPOSURE; HISTOPATHOLOGY; HUMAN; LUNG CANCER; OCCUPATIONAL HEALTH; PATHOGENESIS; PLEURA DISEASE; PROGNOSIS; RISK ASSESSMENT; SMOKING CESSATION; TREATMENT OUTCOME; EXPOSURE; LUNG TUMOR;

ASBESTOS; HUMANS; INHALATION EXPOSURE; LUNG NEOPLASMS;

EID: 79251644931     PISSN: 00115029     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.disamonth.2010.12.005     Document Type: Article

References (53)

1. Henderson D.W., Rodelsperger K., Woitowitz H.J., et al. After Helsinki: a multidisciplinary review of the relationship between asbestos exposure and lung cancer, with emphasis on studies published during 1997-2004. Pathology 2004, 36(6):517-550.
2. Cancer fact sheet. Facts Sheet number 297 (February 2009) WHO, Accessed: August 4, 2010. http://www.who.int/mediacentre/factsheets/fs297/en/print.html.
3. Murray R. Asbestos: a chronology of its origins and health effects. Br J Ind Med 1990, 47(6):361-365.
4. Gloyne S.R. Pneumoconiossis: a histological survey of necropsy material in 1205 cases. Lancet 1951, 1(6659):810-814.
5. Doll R. Mortality from lung cancer in asbestos workers. Br J Ind Med 1955, 12(2):81-86.
6. Selikoff I.J., Churg J., Hammond E.C. Asbestos exposure and neoplasia. JAMA 1964, 188:22-26.
7. Tweedale G. Asbestos and its lethal legacy. Nat Rev Cancer 2002, 2(4):311-315.
8. Harding A.H., Darnton A., Wegerdt J., et al. Mortality among British asbestos workers undergoing regular medical examinations (1971-2005). Occup Environ Med 2009, 66(7):487-495.
9. Frost G., Harding A.H., Darnton A., et al. Occupational exposure to asbestos and mortality among asbestos removal workers: a Poisson regression analysis. Br J Cancer 2008, 99(5):822-829.
10. Meguellati-Hakkas D., Cyr D., Stucker I., et al. Lung cancer mortality and occupational exposure to asbestos among telephone linemen: a historical cohort study in France. J Occup Environ Med 2006, 48(11):1166-1172.
11. Sullivan P.A. Vermiculite, respiratory disease, and asbestos exposure in Libby, Montana: update of a cohort mortality study. Environ Health Perspect 2007, 115(4):579-585.
12. Camus M., Siemiatycki J., Meek B. Nonoccupational exposure to chrysotile asbestos and the risk of lung cancer. N Engl J Med 1998, 338(22):1565-1571.
13. Luo S., Liu X., Mu S., et al. Asbestos related diseases from environmental exposure to crocidolite in Da-yao, China. I. Review of exposure and epidemiological data. Occup Environ Med 2003, 60(1):35-42.
14. Reid A., Heywork J., de Klerk N., et al. The mortality of women exposed environmentally and domestically to blue asbestos at Wittenoom, western Australia. Occup Environ Med 2008, 65(11):743-749.
15. Weiss W. Asbestos-related pleural plaques and lung cancer. Chest 1993, 103(6):1854-1859.
16. Hillerdal G., Henderson D.W. Asbestos, asbestosis, pleural plaques and lung cancer. Scand J Work Environ Health 1997, 23(2):93-103.
17. Hillerdal G. Pleural plaques and risk for bronchial carcinoma and mesothelioma. A prospective study. Chest 1994, 105(1):144-150.
18. Cullen M.R., Barnett M.J., Balmes J.R., et al. Predictors of lung cancer among asbestos-exposed men in the {beta}-carotene and retinol efficacy trial. Am J Epidemiol 2005, 161(3):260-270.
19. Banks D.E., Shi R., McLarty J., et al. American College of Chest Physicians consensus statement on the respiratory health effects of asbestos. Results of a Delphi study. Chest 2009, 135(6):1619-1627.
20. Hammond E.C., Selikoff I.J., Seidman H. Asbestos exposure, cigarette smoking and death rates. Ann NY Acad Sci 1979, 330:473-490.
21. Lee P.N. Relation between exposure to asbestos and smoking jointly and the risk of lung cancer. Occup Environ Med 2001, 58(3):145-153.
22. Liddell F.D.K. The interaction of asbestos and smoking in lung cancer. Ann Occup Hyg 2001, 45(5):341-356.
23. Reid A., de Klerk N.H., Ambrosini G.L., et al. The risk of lung cancer with increasing time since ceasing exposure to asbestos and quitting smoking. Occup Environ Med 2006, 63(8):509-512.
24. Heintz N.H., Janssen-Heininger Y.M., Mossman B.T., et al. Lung cancers, and mesotheliomas: from molecular approaches to targeting tumor survival pathways. Am J Respir Cell Mol Biol 2010, 42(2):133-139.
25. Linardou H., Dahabreh I.J., Kanaloupiti D., et al. Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer. Lancet Oncol 2008, 9(10):962-972.
26. Nelson H.H., Christiani D.C., Wiencke J.K., et al. k-ras mutation and occupational asbestos exposure in lung adenocarcinoma: asbestos-related cancer without asbestosis. Cancer Res 1999, 59(18):4570-4573.
27. Dostert C., Petrilli V., Van Bruggen R., et al. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008, 320(5876):674-677.
28. Asbestosis W.W. A marker for the increased risk of lung cancer among workers exposed to asbestos. Chest 1999, 115(2):536-549.
29. Reid A., de Klerk N., Ambrosini G.L., et al. The effect of asbestosis on lung cancer risk beyond the dose related effect of asbestos alone. Occup Environ Med 2005, 62(12):885-889.
30. Ross R.M. The clinical diagnosis of asbestosis in this century requires more than a chest radiograph. Chest 2003, 124(3):1120-1128.
31. Sluis-Cremer G.K., Bezuidenhout B.N. Relation between asbestosis and bronchial cancer in amphibole asbestos miners. Br J Ind Med 1989, 46(8):537-540.
32. Oksa P., Klockars M., Karjalainen A., et al. Progression of asbestosis predicts lung cancer. Chest 1998, 113(6):1517-1521.
33. Hessel P.A., Gamble J.F., McDonald J.C., et al. Asbestosis, and lung cancer: a critical assessment of the epidemiological evidence. Thorax 2005, 60(5):433-436.
34. Stayner L.T., Dankovic D.A., Lemen R.A. Occupational exposure to chrysotile asbestos and cancer risk: a review of the amphibole hypothesis. Am J Public Health 1996, 86(2):179-186.
35. Loomis D., Dement J., Richardson D., et al. Asbestos fibre dimensions and lung cancer mortality among workers exposed to chrysotile. Occup Environ Med 2010, 67(9):580-584.
36. Churg A. Lung cancer cell type and asbestos exposure. JAMA 1985, 253(20):2984-2985.
37. Lee B.W., Wain J.C., Kelsey K.T., et al. Association of cigarette smoking and asbestos exposure with location and histology of lung cancer. Am J Respir Crit Care Med 1998, 157(3 Pt 1):748-755.
38. Karjalainen A., Anttila S., Heikkila L., et al. Lobe of origin of lung cancer among asbestos-exposed patients with or without diffuse interstitial fibrosis. Scand J Work Environ Health 1993, 19(2):102-107.
39. Weiss W. Asbestosis and lobar site of lung cancer. Occup Environ Med 2000, 57(5):358-360.
40. Guidotti T.L. American Thoracic Society documents. diagnosis and initial management of nonmalignant diseases related to asbestos. Am J Respir Crit Care Med 2004, 170:691-715.
41. Vierikko T., Jarvenpaa R., Autti T., et al. Chest CT screening of asbestos-exposed workers: lung lesions and incidental findings. Eur Respir J 2007, 29(1):78-84.
42. Clin B., Morlais F., Guittet L., et al. Performance of chest radiograph and CT scan for lung cancer screening in asbestos-exposed workers. Occup Environ Med 2009, 66(8):529-534.
43. Tossavainen A. International expert meeting on new advances in the radiology and screening of asbestos-related diseases. Scand J Work Environ Health 2000, 26(5):449-454.
44. Ghosal R., Kloer P., Lewis K.E. A review of novel biological tools used in screening for the early detection of lung cancer. Postgrad Med J 2009, 85(1005):358-363.
45. Lam B., Lam S.Y., Wong M.P., et al. Sputum cytology examination followed by autofluorescence bronchoscopy: a practical way of identifying early stage lung cancer in central airway. Lung Cancer 2009, 64(3):289-294.
46. Loewen G., Natarajan N., Tan D., et al. Autofluorescence bronchoscopy for lung cancer surveillance based on risk assessment. Thorax 2007, 62(4):335-340.
47. van Klaveren R.J., Oudkerk M., Prokop M., et al. Management of lung nodules detected by volume CT scanning. N Engl J Med 2009, 361(23):2221-2229.
48. McAdams H.P., Erasmus J.J., Patz E.F., et al. Evaluation of patients with round atelectasis using 2-[18F]fluoro-2-deoxy-d-glucose PET. J Comput Assist Tomogr 1998, 22(4):601-604.
49. Henderson D.W. Asbestos, asbestosis, and cancer: the Helsinki criteria for diagnosis and attribution. Consensus report. Scand J Work Environ Health 1997, 23:311-316.
50. Bapoje S.R., Whitaker J.F., Schulz T., et al. Preoperative evaluation of the patient with pulmonary disease. Chest 2007, 132(5):1637-1645.
51. Peto R., Darby S., Deo H., et al. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ 2000, 321(7257):323-329.
52. Omenn G.S., Goodman G.E., Thornquist M.D., et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996, 334(18):1150-1155.
53. Ak G., Metintas M., Metintas S., et al. Characteristics of lung cancer patients with asbestos-related radiological findings. Tuberk Toraks 2008, 56(3):257-265.